Delcath Systems Inc (DCTH)

[benandemmiboo]

8 million dollar valuation at the moment. Meanwhile, RTTR has yet to prove it does not have a placebo, but 16 million market cap (even after dropping 90 percent). LVCLY was also recently unable to prove its product is nothing more than a placebo, and it too has a 16-17 million market cap.
Apparently there is an interest to keep the DCTH price low, but common sense suggests this stock should be valued much higher than the present day.

____

BTW, Rennova now up 38 percent on no news (with shareholders completely clueless about its share count) while DCTH up 15 percent on news that the big dilution from convertibles is done.